WAO/EAACI遺伝性血管性浮腫治療ガイドライン―2021年改定版

DOI Web Site
  • Maurer M.
    Institute of Allergology, Charité—Universitätsmedizin, Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology
  • Magerl M.
    Institute of Allergology, Charité—Universitätsmedizin, Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology
  • Betschel S.
    University of Toronto
  • Aberer W.
    Department of Dermatology, Medical University of Graz
  • Ansotegui I. J.
    Department of Allergy & Immunology, Hospital Quironsalud Bizkaia
  • Aygören-Pürsün E.
    Center for Children and Adolescents, University Hospital Frankfurt
  • Banerji A.
    Division of Rheumatology, Allergy and Immunology, Massachusetts General Hospital
  • Bara N. A.
    Romanian Hereditary Angioedema Expertise Centre, Mediquest Clinical Research Center
  • Boccon-Gibod I.
    National Reference Center for Angioedema (CREAK), Angioedema Center of Reference and Excellence (ACARE), Grenoble Alpes University Hospital
  • Bork K.
    Department of Dermatology, University Medical Center, Johannes Gutenberg University
  • Bouillet L.
    National Reference Center for Angioedema (CREAK), Angioedema Center of Reference and Excellence (ACARE), Grenoble Alpes University Hospital
  • Boysen H. B.
    HAE International (HAEi)
  • Brodszki N.
    Department of Pediatric Immunology, Childrens Hospital, Skåne University Hospital
  • Busse P. J.
    Icahn School of Medicine at Mount Sinai
  • Bygum A.
    Clinical Institute, University of Southern Denmark Department of Clinical Genetics, Odense University Hospital
  • Caballero T.
    Allergy Department, Hospital Universitario La Paz
  • Cancian M.
    Department of Systems Medicine, University Hospital of Padua
  • Castaldo A.
    HAE International (HAEi)
  • Cohn D. M.
    Department of Vascular Medicine, Amsterdam UMC/University of Amsterdam
  • Csuka D.
    Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University
  • Farkas H.
    Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University
  • Gompels M.
    Clinical Immunology, North Bristol NHS Trust
  • Gower R.
    Marycliff Clinical Research, Principle Research Solutions
  • Grumach A. S.
    Clinical Immunology, Centro Universitario FMABC
  • Guidos-Fogelbach G.
    Instituto Politécnico Nacional SEPI-ENMH
  • Hide M.
    Department of Dermatology, Hiroshima Citizens Hospital Department of Dermatology, Hiroshima University
  • Kang H. R.
    Department of Internal Medicine, Seoul National University College of Medicine
  • Kaplan A. P.
    Division of Pulmonary, Critical Care, Allergy and Immunology, Medical University of South Carolina
  • Katelaris C.
    Department of Medicine, Campbelltown Hospital and Western Sydney University
  • Kiani-Alikhan S.
    Department of Immunology, Barts Health NHS Trust
  • Lei W. T.
    Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Mackay Memorial Hospital
  • Lockey R.
    Division of Allergy and Immunology, Department of Internal Medicine, Morsani College of Medicine, University of South Florida
  • Longhurst H.
    Department of Immunology, Auckland District Health Board and Department of Medicine, University of Auckland
  • Lumry W. R.
    Internal Medicine, Allergy Division, University of Texas Health Science Center
  • MacGinnitie A.
    Division of Immunology, Department of Pediatrics, Boston Children's Hospital, Harvard Medical School
  • Malbran A.
    Unidad de Alergia, Asma e Inmunología Clínica
  • Saguer I. M.
    Pediatrics, Haemophilia Centre Rhine Main (HZRM)
  • Matta J. J.
    H. Especialidades C.M.N.SXXI, I.M.S.S.
  • Nast A.
    Department of Dermatology, Venereology and Allergology, Division of Evidence-Based Medicine Charité-Universitätsmedizin Berlin, corporate member of Free University of Berlin, Humboldt University of Berlin, and Berlin Institute of Health
  • Nguyen D.
    Respiratory, Allergy and Clinical Immunology Unit, Internal Medicine Department, Vinmec Healthcare System, College of Health Sciences, VinUniversity
  • Nieto-Martinez S. A.
    Genetic Unit of Nutrition, National Institute of Pediatrics
  • Pawankar R.
    Department of Pediatrics, Nippon Medical School
  • Peter J.
    Division of Allergy and Clinical Immunology, University of Cape Town Allergy and Immunology Unit, University of Cape Town Lung Institute
  • Porebski G.
    Department of Clinical and Environmental Allergology, Jagiellonian University Medical College
  • Prior N.
    Allergy, Hospital Universitario Severo Ochoa
  • Reshef A.
    Angioderma Center, Barzilai University Medical Center
  • Riedl M.
    Division of Rheumatology, Allergy and Immunology, University of California San Diego
  • Ritchie B.
    Departments of Medicine and Medical Oncology, University of Alberta
  • Sheikh F. R.
    Section of Adult Allergy & Immunology, Department of Medicine, King Faisal Specialist Hospital & Research Centre
  • Smith W. B.
    Clinical Immunology and Allergy, Royal Adelaide Hospital
  • Spaeth P. J.
    Institute of Pharmacology, University of Bern
  • Stobiecki M.
    Department of Clinical and Environmental Allergology, Jagiellonian University Medical College
  • Toubi E.
    Division of Allergy and Clinical Immunology, Bnai Zion Medical Center, Affiliated with Rappaport Faculty of Medicine, Technion-Israel Institute of Technology
  • Varga L. A.
    Department of Internal Medicine and Haematology, Hungarian Angioedema Center of Reference and Excellence, Semmelweis University
  • Weller K.
    Institute of Allergology, Charité—Universitätsmedizin, Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Immunology and Allergology
  • Zanichelli A.
    Department of Internal Medicine, ASST Fatebenefratelli Sacco, Ospedale Luigi Sacco-University of Milan
  • Zhi Y.
    Department of Allergy and Clinical Immunology, Bejing Union Medical College Hospital & Chinese Academy of Medical Sciences
  • Zuraw B.
    University of California, San Diego
  • Craig T.
    Departments of Medicine and Pediatrics, Penn State University

書誌事項

タイトル別名
  • 特集 WAO/EAACI遺伝性血管性浮腫治療ガイドライン : 2021年改定版
  • トクシュウ WAO/EAACI イデンセイ ケッカンセイ フシュ チリョウ ガイドライン : 2021ネン カイテイバン

この論文をさがす

抄録

<p>遺伝性血管性浮腫（HAE）は，身体機能障害をもたらす稀少疾患で，早期診断と効果的な治療が重要である．本稿は，HAEの診断と管理に関するWAO/EAACIの国際ガイドラインの改定と更新により，HAEの管理に関する最新のガイダンスを提供する．国際専門家委員会は，本ガイドラインの更新と改定のために既存のエビデンスを検討し，28の推奨事項を作成してオンラインのDELPHIプロセスによってコンセンサスを確立した．これらの推奨事項とガイドラインの目的は，医師とその患者が，C1インヒビターの欠損によるHAE（タイプ1）および機能不全のC1インヒビターによるHAE（タイプ2）の管理において以下のような共通かつ重要な臨床的問題に関する指針を提供し，合理的な決定を下すのに役立つことである．（1）HAEはどのように診断されるべきか?（2）HAE患者はオンデマンド治療に加えていつ予防薬を受けるべきか?また，どのような治療法を使用すべきか?（3）治療のゴールは何か？（4）子供や妊娠中/授乳中の女性などの特定のHAE患者グループではHAEの管理を変える必要があるか?（5）HAE患者は，どのように疾患の活動性，影響，およびコントロールをモニターすべきか? また，本ガイドラインは，HAEの管理に関する国際基準の確立を支援し，すべての患者に対して推奨される診断と治療の使用を奨励および促進することを目的としている．</p>

収録刊行物

  • アレルギー

    アレルギー 72 (3), 237-272, 2023

    一般社団法人 日本アレルギー学会

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ